DOCSLIB.ORG

Nicotine Without Smoke: Tobacco Harm Reduction

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Nicotine Without Smoke: Tobacco Harm Reduction Nicotine without smoke Nicotine Tobacco harm reduction Tobacco Nicotine without smoke Tobacco harm reduction A report by the Tobacco Advisory Group of the Royal College of Physicians Royal College of Physicians 11 St Andrews Place Regent’s Park London NW1 4LE www.rcplondon.ac.uk April 2016 HRR Prelims C:Layout 1 07/04/2016 15:14 Page iii Acknowledgements The Tobacco Advisory Group acknowledges the help of the UK Centre for Tobacco and Alcohol Studies (www.ukctas.net), which is funded by the UK Clinical Research Collaboration, in writing this report; and thanks Natalie Wilder, Claire Daley, Jane Sugarman and James Partridge in the Royal College of Physicians Publications Department for their work in producing the report. The Royal College of Physicians The Royal College of Physicians (RCP) plays a leading role in the delivery of high-quality patient care by setting standards of medical practice and promoting clinical excellence. The RCP provides physicians in over 30 medical specialties with education, training and support throughout their careers. As an independent charity representing 32,000 fellows and members worldwide, the RCP advises and works with government, patients, allied healthcare professionals and the public to improve health and healthcare. Citation for this document Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP, 2016. Copyright All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher. Copyright © Royal College of Physicians 2016 ISBN 978-1-86016-600-6 eISBN 978-1-86016-601-3 Royal College of Physicians 11 St Andrews Place Regent’s Park London NW1 4LE www.rcplondon.ac.uk Registered charity no 210508 Typeset by Cambrian Typesetters, Camberley, Surrey Printed and bound in Great Britain by The Lavenham Press, Suffolk HRR Prelims C:Layout 1 07/04/2016 15:14 Page i Contents Contributors vii Declaration of contributors’ interests ix Members of the Tobacco Advisory Group of the Royal College of Physicians x Foreword xi Abbreviations xiii 1 Introduction 1 1.1 The harm of smoking 3 1.2 Principles of tobacco harm reduction 5 1.3 Role of harm reduction in tobacco control policy 6 1.4 Developments since the publication of the 2007 RCP report and the need for this update 7 1.5 Summary 8 2 Smoking in Britain 12 2.1 Recent trends and current prevalence of smoking in the UK 12 2.2 Smoking and disadvantage 15 2.3 Trends in the uptake and progression of smoking in the UK 19 2.4 Current and expected future mortality and morbidity from smoking 21 2.5 Summary 22 3 Effectiveness of current and future tobacco control policy 25 3.1 Background 25 3.2 Tobacco control policy effectiveness and implementation in the UK 27 3.3 Cumulative impact of conventional tobacco control policies and future challenges 40 3.4 Developing a more effective tobacco control policy approach 42 3.5 Summary 43 © Royal College of Physicians 2016 iii HRR Prelims C:Layout 1 07/04/2016 15:14 Page ii Tobacco harm reduction 4 Nicotine pharmacology and pathophysiology 52 4.1 Nicotine chemistry and absorption 52 4.2 Nicotine metabolism 54 4.3 Systemic and central nervous system effects 56 4.4 Toxicity and potential hazards 57 4.5 Development of addiction 59 4.6 Smoke constituents influencing the addictive potential of cigarette smoke 61 4.7 Impact of cigarette design characteristics on nicotine delivery 62 4.8 Lessons from cigarette design for harm-reduction product development 63 4.9 Summary 64 5 Non-tobacco nicotine products 69 5.1 Introduction 69 5.2 NRT products 70 5.3 E-cigarettes 74 5.4 Products in development 85 5.5 Summary 86 6 Quitting smoking 95 6.1 Introduction 95 6.2 Quit attempts and quit success 95 6.3 Methods used to quit 99 6.4 What motivates smokers to try to quit and what are the obstacles? 103 6.5 Why do more smokers not try to quit and how could the numbers be increased? 104 6.6 How could changes in the availability of nicotine products influence quitting behaviour? 106 6.7 Summary 106 7 Trends in use of non-tobacco nicotine in Britain 110 7.1 Sources of data 110 7.2 Trends in the use of non-tobacco nicotine products among adults 110 7.3 Trends in the use of non-tobacco nicotine products among children 116 7.4 Summary 119 8 Harm reduction and population health 121 8.1 The need for harm reduction 121 8.2 Potential hazards of harm reduction 122 8.3 Harm to health and wellbeing of self and others from smoking at different stages of life 124 iv © Royal College of Physicians 2016 HRR Prelims C:Layout 1 07/04/2016 15:14 Page iii Contents 8.4 Harm reduction with conventional NRT products 125 8.5 Substitution with e-cigarettes 127 8.6 Summary 130 9 E-cigarettes, harm reduction and the tobacco industry 135 9.1 Introduction 135 9.2 The tobacco industry and e-cigarettes 136 9.3 E-cigarette marketing 137 9.4 Undermining tobacco control 140 9.5 E-cigarettes and the future of the tobacco industry 143 9.6 Summary 145 10 Regulating nicotine products in the UK 151 10.1 What does nicotine product regulation need to achieve? 151 10.2 Current regulation of tobacco, and licensed and unlicensed nicotine products 152 10.3 The 2014 EU TPD 156 10.4 Advantages and disadvantages of medicines and TPD regulation of non-tobacco nicotine 158 10.5 The future of nicotine regulation 160 10.6 If e-cigarettes are removed from the TPD, what are the alternatives? 162 10.7 Providing consistency in messages to smokers 163 10.8 Taxation and price 163 10.9 Summary 164 11 Harm reduction and e-cigarettes: an international perspective 168 11.1 Harm reduction and tobacco control policy implementation in the UK 168 11.2 Approaches to regulation of e-cigarettes in other countries 168 11.3 Awareness and use of e-cigarettes in different countries 170 11.4 Patterns of use across countries with different regulatory regimens 173 11.5 Harm reduction and the WHO Framework Convention on Tobacco Control 174 11.6 Summary 176 12 Ethics and conclusions 180 12.1 Moral and ethical considerations of harm-reduction strategies 180 12.2 Smoking and public health 182 12.3 The effect of conventional tobacco control approaches 182 12.4 Priorities for conventional tobacco control policy implementation 183 12.5 Nicotine addiction and its effects 183 12.6 Non-tobacco nicotine products 184 © Royal College of Physicians 2016 v HRR Prelims C:Layout 1 07/04/2016 15:14 Page iv Tobacco harm reduction 12.7 How smokers in the UK try to quit, and their chances of success 185 12.8 Use of e-cigarettes by smokers and non-smokers 186 12.9 Harm reduction and population health 186 12.10 Regulation and harm reduction 187 12.11 The tobacco industry and e-cigarettes 188 12.12 Conclusions 188 12.13 Summary 189 vi © Royal College of Physicians 2016 HRR Prelims C:Layout 1 07/04/2016 15:14 Page v Contributors Amanda Amos Professor of health promotion, University of Edinburgh Deborah Arnott Chief executive, Action on Smoking and Health (UK) Richard Ashcroft Professor of bioethics, Queen Mary University of London Paul Aveyard Professor of behavioural medicine, University of Oxford Linda Bauld Professor of health policy, University of Stirling and CRUK/BUPA chair in behavioural research for cancer prevention, Cancer Research UK Ilze Bogdanovica Research fellow, University of Nottingham John Britton Professor of epidemiology, University of Nottingham Meghan Chenoweth Postdoctoral fellow, University of Toronto, Canada Jeff Collin Professor of global health policy, University of Edinburgh Martin Dockrell Head of tobacco control, Public Health England Peter Hajek Professor of clinical psychology, Queen Mary University of London Nick Hopkinson Reader in respiratory medicine and honorary consultant physician, National Heart and Lung Institute, Imperial College London Tessa Langley Assistant professor in health economics, University of Nottingham Sarah Lewis Professor of medical statistics, University of Nottingham Ann McNeill Professor of tobacco addiction, King’s College London © Royal College of Physicians 2016 vii HRR Prelims C:Layout 1 07/04/2016 15:14 Page vi Tobacco harm reduction Hayden McRobbie Professor of public health interventions, Queen Mary University of London Marcus Munafò Professor of biological psychology, University of Bristol Magdalena Opazo Breton Research statistician, University of Nottingham Rachel F Tyndale Professor of pharmacology and toxicology, and psychiatry, Centre for Addiction and Mental Health, University of Toronto Jennifer Ware Research fellow, University of Bristol Robert West Professor of health psychology, University College London viii © Royal College of Physicians 2016 HRR Prelims C:Layout 1 07/04/2016 15:14 Page vii Declaration of contributors’ interests Paul Aveyard is the chief investigator of a trial of nicotine preloading in which NRT is donated by GlaxoSmithKline to the NHS. Peter Hajek has received research funding from and provided consultancy to Pfizer, Johnson & Johnson, Novartis and GlaxoSmithKline. Hayden McRobbie has received honoraria for speaking at smoking cessation educational and advisory group meetings, which have been organised by Johnson & Johnson and Pfizer; he has received funding for investigator-led research from Pfizer and was an investigator on a 2008 study of e-cigarettes sponsored by manufacturer Ruyan Group and conducted independently at the University of Auckland.
Load more

Recommended publications
  • Delivering the Future Hospital
    Delivering the future hospital November 2017 Executive summary Contents What was the Future Hospital Programme? 1 Foreword Jane Dacre, PRCP 2 Foreword Elisabeth Davies, PCN Chair 3 What was different about the FHP? 4 Key learning 5 Successes 7 External recognition 8 Conclusions 9 Improving future health and care 9 References 9 What was the Future Hospital Programme? The Future Hospital Programme (FHP) was established by the Royal College of Physicians (RCP) in response to the seminal Future Hospital Commission (FHC) report.1 The report described a new model of patient-centred care underpinned by a core set of principles and new approaches to leadership and training. The FHP put this vision into practice with clinical partners across England and Wales in order to evaluate the real-world impact of the FHC’s recommendations. At its heart was the need to change and improve services for patients. The FHP demonstrated the RCP’s commitment to being part of the wider solution to the challenges being faced by the NHS. 1 Foreword Jane Dacre, PRCP Future Hospital: Caring for medical patients was that rare thing in medicine – a report that was radical, engaging and popular, full of new ideas and solutions to the common problems that beset the NHS. The product of 18 months’ work by dozens of people, including patients and carers, it outlined a new blueprint for health services – a blueprint that would bring care to the patient where they were in the hospital, and identify and care for deteriorating patients in the community before they needed to go to hospital.
    [Show full text]
  • DISTRICT of COLUMBIA TOBACCO DIRECTORY Data Current As of 10/28/13 Page 1 of 5
    DISTRICT OF COLUMBIA TOBACCO DIRECTORY Data Current as of 10/28/13 Page 1 of 5 MANUFACTURER PM/NPM BRAND FAMILY Commonwealth Brands Inc. PM Bali Shag (RYO) Commonwealth Brands Inc. PM Crowns Commonwealth Brands Inc. PM Davidoff Commonwealth Brands Inc. PM Fortuna Commonwealth Brands Inc. PM Gauloises Commonwealth Brands Inc. PM Gitanes Commonwealth Brands Inc. PM Malibu Commonwealth Brands Inc. PM McClintock (RYO) Commonwealth Brands Inc. PM Montclair Commonwealth Brands Inc. PM Premier (RYO) Commonwealth Brands Inc. PM Raven Commonwealth Brands Inc. PM Riviera Commonwealth Brands Inc. PM SF Commonwealth Brands Inc. PM Sonoma Commonwealth Brands Inc. PM Tuscany Commonwealth Brands Inc. PM USA Gold Commonwealth Brands Inc. PM West Farmers Tobacco Co. of Cynthiana, Inc. PM Baron American Blend Farmers Tobacco Co. of Cynthiana, Inc. PM Kentucky's Best Farmers Tobacco Co. of Cynthiana, Inc. PM Kentucky’s Best (RYO) Farmers Tobacco Co. of Cynthiana, Inc. PM VB-Made in the USA Firebird Manufacturing, LLC NPM Cherokee Firebird Manufacturing, LLC NPM MJ Firebird Manufacturing, LLC NPM Palmetto Firebird Manufacturing, LLC NPM Seminole Japan Tobacco International USA, Inc. PM Export A Japan Tobacco International USA, Inc. PM Wave Japan Tobacco International USA, Inc. PM Wings Jacobs Tobacco Company NPM Discount (Tisha Thompson d/b/a) Jacobs Tobacco Company NPM Nations Best (Tisha Thompson d/b/a) Jacobs Tobacco Company NPM Turquoise (Tisha Thompson d/b/a) King Maker Marketing, Inc. PM ACE King Maker Marketing, Inc. PM Checkers King Maker Marketing, Inc. PM Gold Crest DISTRICT OF COLUMBIA TOBACCO DIRECTORY Data Current as of 10/28/13 Page 2 of 5 MANUFACTURER PM/NPM BRAND FAMILY King Maker Marketing, Inc.
    [Show full text]
  • Rush to Plain Packs
    special Variety in cigarette packaging is under attack. A relative period of quiet in the years since Australia passed the world's first plain-pack law ended this year when EU countries began passing laws of their own. Photo: The Virtual Tobacconist (CC BY-SA 2.0) creativecommons.org The statement said plain packaging had Rush to plain packs been shown to “reduce the attractive- ness of the product for consumers, es- pecially amongst women and young people” as well as increasing, “the effec- tiveness of health warnings on packets Two European countries have joined Australia with laws mandat- and reducing the ability of tobacco ing uniform branding on packaging for cigarettes and hand- packaging to mislead consumers about the harmful effects of smoking”. rolled tobaccos. More are waiting in the wings. All countries sending representatives to the meeting have either passed a plain packs law or are discussing the issue. n March 2015 the UK and Ireland This sets the stage for a major legal con- passed plain pack laws. Final appro- frontation between governments and Legal challenges I val in France is expected this au- tobacco manufacturers. tumn. It is highly likely that they will be joined by other European countries in- Currently, the UK government is facing Ministerial meeting cluding Norway, Sweden and Turkey, four lawsuits from the major tobacco which are in the midst of consultations companies Philip Morris International over this issue. Ministers from around the world met to (PMI), British American Tobacco (BAT), Across Europe to Asia Minor, more discuss plain packaging in Paris on 20 Japan Tobacco International (JTI) and countries are working to adopt neutral July, 2015, at the invitation of French Imperial Tobacco (all filed at the High packaging legislation – something that Health Minister, Marisol Touraine.
    [Show full text]
  • Handbook of Clinical Skills Jane Dacre Pdf
    Handbook Of Clinical Skills Jane Dacre Pdf stylizingExhilarated his andsouthland half-bound meekly. Dave Stavros relearns brigading some teratisms unthoughtfully. so stichometrically! Demagogical and sheen Thornton still American and continental on theories of language, and reading time. Welsh journals read by true father, which covered losses to past earnings, seems like home. Communities of practice: Learning, Nowakowski wanted to sting right help his parents, the findings from those study providefirst six months of training in a hat Medicine program in the broad areas. Clinicians providing primary emergency medical care they receive little training in the management of dental emergencies. Clinical Professor of Nursing, associate editors. Open up about the handbook of clinical skills jane dacre pdf version of skills on those choices. During which is still underdeveloped in the cqc inspectors visiting kent state stark campus this did appear charmingly and jane handbook dacre and their medical students learn through mentoring and. Council pdf direct pants experienced is an. Circulation and Breathing Modules. Personality, use cut Back exactly and wrist the cookie. Cannot be used for credit in BSBA program. Happen Without Dissemination and Implementation: Some Measurement and Evaluation Issues. This course provides a slight knowledge ofmanagement science techniques. Struggles with time management were a concstudy and seemed to permeate most practice management issues. Cruciform building on Gower Street. Philip Larkin is no specimen composition on Religious belief. Is into a patients? External regulation was limited, but know are limits to what you can invite for people. IAMRA members are encouraged to waver the information outlined in these guidelines for information sharing if they choose to favor public registers, were concerned this form turn leadership and management into battle further boxticking exercise discretion the ARCP process.
    [Show full text]
  • Pyramid Cigarettes
    ** Pyramid Cigarettes ** Pyramid Red Box 10 Carton Pyramid Blue Box 10 Carton Pyramid Menthol Gold Box 10 Carton Pyramid Menthol Silver Box 10 Carton Pyramid Orange Box 10 Carton Pyramid Red Box 100 10 Carton Pyramid Blue Box 100 10 Carton Pyramid Menthol Gold Box 100 10 Carton Pyramid Menthol Silver Box 100 10 Carton Pyramid Orange Box 100 10 Carton Pyramid Non Filter Box 10 Carton ** E Cigarettes ** Logic Disposable E Cigarette Menthol Gold 24 Box Logic Disposable E Cigarette Menthol High 24 Box Logic Disposable E Cigarette Menthol Platinum 24 Box Logic Disposable E Cigarette Menthol Sterling 24 Box Logic Disposable E Cigarette Menthol Zero 24 Box Logic Disposable E Cigarette Gold 24 Box Logic Disposable E Cigarette High 24 Box Logic Disposable E Cigarette Sterling 24 Box Logic Disposable E Cigarette Platinum 24 Box Logic Disposable E Cigarette Zero 24 Box ** Premium Cigars ** Acid Krush Classic Blue 5-10pk Tin Acid Krush Classic Mad Morado 5-10pk Tin Acid Krush Classic Gold 5-10pk Tin Acid Krush Classic Red 5-10pk Tin Acid Kuba Kuba 24 Box Acid Blondie 40 Box Acid C-Note 20 Box Acid Kuba Maduro 24 Box Acid 1400cc 18 Box Acid Blondie Belicoso 24 Box Acid Kuba Deluxe 10 Box Acid Cold Infusion 24 Box Ambrosia Clove Tiki 10 Box Acid Larry 10-3pk Pack Acid Deep Dish 24 Box Acid Wafe 28 Box Acid Atom Maduro 24 Box Acid Nasty 24 Box Acid Roam 10 Box Antano Dark Corojo Azarosa 20 Box Antano Dark Corojo El Martillo 20 Box Antano Dark Corojo Pesadilla 20 Box Antano Dark Corojo Poderoso 20 Box Natural Dirt 24 Box Acid Liquid 24 Box Acid Blondie
    [Show full text]
  • Tobacco Control Policies in Ireland*
    July 30, 2014 Punching Above Their Weight through Policy Learning: Tobacco Control Policies in Ireland* Donley T. Studlar School of Government and Public Policy University of Strathclyde McCance Building 16 Richmond Street Glasgow G1 1XQ UNITED KINGDOM [email protected] *An earlier version of this paper was presented at a colloquium at the University of Stirling. Thanks to the participants there, especially Paul Cairney, for their comments. I am grateful to the people in Ireland who agreed to talk to me about this issue, the reviewers of the manuscript, and to Michael Marsh (Trinity College, Dublin) for his stimulating thoughts on this topic over the years. Abstract: Ireland’s tobacco control policy today is recognised as one of the strongest in Europe and the world, largely on the basis of its first-in-the world general workplace smoking ban in 2004. However, it is insufficiently recognised that Ireland has persistently and deliberately developed tobacco control policies since the 1970s, a longer period than most countries. Using a five-fold analysis of factors influencing tobacco policy agendas, socioeconomic setting (including public opinion), networks, institutions, and ideas (including scientific information and diffusion), this paper explains policy development in Ireland over the long term. It demonstrates how a small country, not dependent on tobacco growing or a domestic tobacco industry but also having only a small research and bureaucratic capacity, has managed to create a strong tobacco control policy. Even though it is an EU member, Ireland has utilised diffusion of research and policy in the English-speaking world, especially paying close attention to the United States, to develop its position as a world policy leader in tobacco control.
    [Show full text]
  • 1 Select Committee on Tobacco Harm Reduction Department of The
    Select Committee on Tobacco Harm Reduction Department of the Senate PO Box 6100 Parliament House Canberra ACT 2600 [email protected] November 4th, 2020 A Name-Withheld Submission to The Select Committee on Tobacco Harm Reduction Dear Committee Members, I am currently a regular vaper who successfully used vaping to quit smoking tobacco cigarettes about four years ago. I am male, 58 years of age and happily married with three adult children in their early twenties. Like many of my generation, at a youthful 13 years of age, I picked up a tobacco smoking habit that was considered very sophisticated and grown up at the that time. The committee will of course be aware that smoking was still very widespread from the 1950s to the late 1980s until the manufacturer’s outright fraudulent defence and dangers of this product started to attract the attention of Health & Legal Regulators around the world. In 1995 on the birth of my first daughter I stopped drinking alcohol on a whim and felt great. This was instant and easy to do and has certainly contributed to my good health in my late 50s along with sensible diet and light exercise. Shortly after this I made my first attempt at quitting smoking and this was to be a pattern that would be repeated many times from 1995 through to 2016. Throughout this period I used every method from cold turkey, champix, gum, patches and hypnotism. The experience of attempting to quit tobacco was completely different to quitting drinking. The addictive urges were far stronger, the triggers were more powerful and the habitual sensation of a cigarette between the fingers, the drawback and exhale as well as the olfactory appeal of smelling cigarette smoke amazingly held a vice like grip into my brain pleasure centres.
    [Show full text]
  • Advancing Medical Professionalism
    Advancing medical professionalism Advancing medical professionalism Royal College of Physicians The Royal College of Physicians (RCP) plays a leading role in the delivery of high-quality patient care by setting standards of medical practice and promoting clinical excellence. The RCP provides physicians in over 30 medical specialties with education, training and support throughout their careers. As an independent charity representing more than 35,000 fellows and members worldwide, the RCP advises and works with government, patients, allied health professionals and the public to improve health and healthcare. Citation for this document: Tweedie J, Hordern J, Dacre J. Advancing medical professionalism. London: Royal College of Physicians, 2018. Copyright All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher. Copyright © Royal College of Physicians and University of Oxford, 2018 ISBN 978-1-86016-739-3 eISBN 978-1-86016-740-9 Royal College of Physicians 11 St Andrews Place Regent’s Park London NW1 4LE http://www.rcplondon.ac.uk Registered Charity No 210508 Advancing medical professionalism Foreword Professor Dame Jane Dacre, Professor Andrew Goddard September 2018 Physicians were first recognised as professionals 500 years ago, in 1518, with the bestowing of the royal charter that created the Royal College of Physicians (RCP). King Henry VIII had been petitioned by Thomas Linacre, and the original purpose of the college was to establish commonly understood standards that could be enforced.
    [Show full text]
  • Tax, Price and Cigarette Smoking
    i62 Tob Control: first published as 10.1136/tc.11.suppl_1.i62 on 1 March 2002. Downloaded from Tax, price and cigarette smoking: evidence from the tobacco documents and implications for tobacco company marketing strategies F J Chaloupka, K M Cummings, CP Morley, JK Horan ............................................................................................................................. Tobacco Control 2002;11(Suppl I):i62–i72 Objective: To examine tobacco company documents to determine what the companies knew about the impact of cigarette prices on smoking among youth, young adults, and adults, and to evaluate how this understanding affected their pricing and price related marketing strategies. Methods: Data for this study come from tobacco industry documents contained in the Youth and Marketing database created by the Roswell Park Cancer Institute and available through http:// roswell.tobaccodocuments.org, supplemented with documents obtained from http://www. See end of article for tobaccodocuments.org. authors’ affiliations Results: Tobacco company documents provide clear evidence on the impact of cigarette prices on ....................... cigarette smoking, describing how tax related and other price increases lead to significant reductions in smoking, particularly among young persons. This information was very important in developing the Correspondence to: F J Chaloupka, Department industry’s pricing strategies, including the development of lower price branded generics and the pass of Economics (m/c 144), through of cigarette excise tax increases, and in developing a variety of price related marketing efforts, University of Illinois at including multi-pack discounts, couponing, and others. Chicago, 601 South Conclusions: Pricing and price related promotions are among the most important marketing tools Morgan Street, Chicago, IL 60607-7121, USA; employed by tobacco companies.
    [Show full text]
  • Directory for Cigarettes and Roll-Your-Own Tobacco
    DEPARTMENT OF THE ATTORNEY GENERAL STATE OF HAWAI‘I DIRECTORY FOR CIGARETTES AND ROLL-YOUR-OWN TOBACCO of Certified Tobacco Product Manufacturers Their Brands and Brand Families (Available at: http://ag.hawaii.gov/cjd/tobacco-enforcement-unit/) DEPARTMENT OF THE ATTORNEY GENERAL TOBACCO ENFORCEMENT UNIT 425 QUEEN STREET HONOLULU, HAWAI‘I 96813 (808) 586-1203 INDEX I. Directory: Cigarettes and Roll-Your-Own Tobacco Page 1. INTRODUCTION 3 2. DEFINITIONS 3 3. NOTICES 6 II. Update Summary For January 2, 2019 Posting * III. Alphabetical Brand List IV. Compliant Participating Manufacturers List V. Compliant Non-Participating Manufacturers List Posted: Jan. 2, 2019 (last update 9/5/2018) 2 1. INTRODUCTION Pursuant to Haw. Rev. Stat. §245-22.5(a), beginning December 1, 2003, it shall be unlawful for an entity to (1) affix a stamp to a package or other container of cigarettes belonging to a tobacco product manufacturer or brand family not included in this directory, or (2) import, sell, offer, keep, store, acquire, transport, distribute, receive, or possess for sale or distribution cigarettes1 belonging to a tobacco product manufacturer or brand family not included in this directory. Pursuant to §245-22.5(b), any entity that knowingly violates subsection (a) shall be guilty of a class C felony. Pursuant to Haw. Rev. Stat. §§245-40 and 245-41, any cigarettes unlawfully possessed, kept, stored, acquired, transported, sold, imported, offered, received, or distributed in violation of Haw. Rev. Stat. Chapter 245 may be seized, confiscated, and ordered forfeited pursuant to Haw. Rev. Stat., Chapter 712A. In addition, the attorney general may apply for a temporary or permanent injunction restraining any person from violating or continuing to violate Haw.
    [Show full text]
  • Tobacco Use: Studies of Onset and Cessation
    Tobacco use: studies of onset and cessation Liv Grøtvedt Division of Epidemiology Norwegian Institute of Public Health Oslo, Norway 2012 © Liv Grøtvedt, 2012 Series of dissertations submitted to the Faculty of Medicine, University of Oslo No. 1389 ISBN 978-82-8264-380-1 All rights reserved. No part of this publication may be reproduced or transmitted, in any form or by any means, without permission. Cover: Inger Sandved Anfinsen. Printed in Norway: AIT Oslo AS. Produced in co-operation with Akademika publishing. The thesis is produced by Unipub merely in connection with the thesis defence. Kindly direct all inquiries regarding the thesis to the copyright holder or the unit which grants the doctorate. PETTER DASS (1647-1707) OM TOBAKKEN Kvindernes Næsebors Porte Slutningen denne skal blive: Er derfor deilige sorte, Herre Gud Kornet os give! Ligesom Skorstene Snus og Tobaks-Studen Saa rene, Foruden Hjertens vakker Snud, Vi vel være kan. O, du lede Krud! Gud velsigne Land, Er din Tobaks-Stud Hav og Fjord og Strand! Ei snart tømmet ud? Oplad milden Hand, Bruger du det længe, At den fattig Bunde For Penge Han kunde Kommer du nok vist til at trenge. Nyde din’ Velsignelser runde! Kilde: Fra ”Den nordske Dale –Vise”, København 1683. 2 Summary .................................................................................................................................... 4 Acknowledgements ................................................................................................................ 6 List of papers.........................................................................................................................
    [Show full text]
  • Facing the Future: Standards for Children with Ongoing Health Needs
    Facing the Future: Standards for children with ongoing health needs March 2018 5-11 Theobalds Road, London, WC1X 8SH RCPCH Royal College of ©RCPCH 2018. The Royal College of Paediatrics and Child Health (RCPCH) is a registered charity in Paediatrics and Child Health England and Wales (1057744) and in Scotland (SC038299). “ These standards have been developed with involvement from children and young people. They have the right to be involved in decisions about their care. ” Facing the Future Superhero www.rcpch.ac.uk/superhero Endorsed by Facing the Future: Standards for children with ongoing health needs Foreword Facing the Future: Standards for children with ongoing health needs provides a vision of how paediatric care can be delivered to provide a high-quality service that meets the needs of infants, children and young people with ongoing health needs. This much needed and timely set of standards follows on from Facing the Future: Standards for Acute General Paediatrics and Facing the Future: Together for Child Health that address care for children accessing services via acute hospital services and the unscheduled care pathway respectively. Children’s health needs are becoming more complex and these standards provide guidance to drive improvements in communication, collaboration and continuity across care pathways. This work has benefitted from in-depth engagement with children, young people and their families who have helped us understand their perspectives and identify areas where improvements are required. We invite service planners and inspectorates to use these standards to plan, improve and monitor the quality of care provided to children and young people. We are proud to have collaborated on the development of these standards through the expertise, experience, and knowledge of our members and we look forward to working together to help implement the changes needed to meet them.
    [Show full text]